Explore >> Select a destination
|
You are here 
|
practicalneurology.com | ||
| | | | |
www.nationalelfservice.net
|
|
| | | | | Kirsten Lawson focuses on novel and emerging pharmacotherapy and neuromodulation for people with 'treatment resistant depression'. | |
| | | | |
www.yalemedicine.org
|
|
| | | | | Dr. Sanacora is a Professor of Psychiatry at Yale University and the Director of the Yale Depression Research Program. Dr. Sanacora's work has focused largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders and using this information to inform the development of novel treatment strategies. His preclinical research laboratory explores the effects of stress and pharmaceutical agents on cellular biology, neurophysiology and behavior. His clinical la... | |
| | | | |
www.preventsuffering.org
|
|
| | | | | OPIS is a leading advocate for patients with excruciating cluster headaches to have legal access to certain psychedelics for medical use. | |
| | | | |
www.samwoolfe.com
|
|
| | | Dr Robin Carhart-Harris is a neuropsychopharmacologist (or a 'scientist' if you want to be more general) who works at Imperial College London. In the past, he worked under David Nutt, the former chairman of the Advisory Council on the Misuse of Drugs. Nutt was fired for being a bit nutty (in the eyes of the... | ||
